Bienvenu(e) sur le site de l'Institut Necker Enfants Malades
Mercredi 22 avril 2020
Simon Fillatreau, Matthieu Mahévas, Claude-Agnès Reynaud and Jean-Claude Weill have received funding from the French National Research Agency (ANR)

Do patients who recovered from COVID-19 possess an immunological memory protecting them against reinfection? If so for how long? Will it vary depending on the population considered e.g. the age of the individual, the treatment received, or the severity of the disease during the first exposure? Addressing these questions is directly relevant to public health policies dealing with confinement /deconfinement decisions as well as for vaccination design and utilization.

A team of scientists at Institut Necker-Enfants Malalades and collaborators at Hôpital Henri Mondor coordinated by Simon Fillatreau, Matthieu Mahévas, Claude-Agnès Reynaud and Jean-Claude Weill have received funding from the French National Research Agency (ANR), which established a scientific task force against COVID-19 at the national level, to examine the immunological memory that remains in affected individuals after the resolution of the infection and is the basis for the protective immunity that determines whether affected individuals can be infected twice.

Adresse

Notice: Undefined variable: contact_addr in /homepages/40/d483507699/htdocs/location.php on line 25
Parrain(s)
S.A.R. la Princesse Caroline de Hanovre qui, à travers la Fondation Princesse Grace, soutient déjà la recherche medicale et tout ce qui contribue à soulager les enfants malades en France et dans le monde, a accepté de s'engager à nos cotés pour que ce centre de medecine moleculaire, tourné entre autres vers les pathologies des enfants, prenne de vitesse les maladies et continue à relever les defis actuels.

INEM - Organigramme